Walleye Trading
BEAT

Walleye Trading’s BioTelemetry, Inc. BEAT Stock Holding History

Walleye Trading’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,600
Closed -$115K – 5711
2020
Q4 		$115K Buy
1,600
+1,300
+433% +$68K ﹤0.01% 3867
2020
Q3 		$14K Sell
300
-7,900
-96% -$330K ﹤0.01% 3877
2020
Q2 		$371K Buy
8,200
+6,300
+332% +$282K ﹤0.01% 2528
2020
Q1 		$73K Buy
+1,900
New +$87.5K ﹤0.01% 3288
2019
Q4 		– Sell
-6,000
Closed -$244K – 4887
2019
Q3 		$244K Buy
+6,000
New +$259K ﹤0.01% 2787
2019
Q2 		– Sell
-3,100
Closed -$194K – 4819
2019
Q1 		$194K Sell
3,100
-20,600
-87% -$1.42M ﹤0.01% 3055
2018
Q4 		$1.42M Buy
23,700
+12,900
+119% +$775K 0.01% 1365
2018
Q3 		$696K Buy
10,800
+3,300
+44% +$184K ﹤0.01% 2505
2018
Q2 		$338K Buy
7,500
+2,900
+63% +$116K ﹤0.01% 3196
2018
Q1 		$143K Sell
4,600
-24,000
-84% -$789K ﹤0.01% 3728
2017
Q4 		$858 Buy
28,600
+2,500
+10% +$72.4K ﹤0.01% 2082
2017
Q3 		$865 Buy
26,100
+24,400
+1,435% +$845K ﹤0.01% 2006
2017
Q2 		$56 Buy
+1,700
New +$50.7K ﹤0.01% 3844

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Walleye Trading's BEAT Position: Q2 2020 in Review

Walleye Trading sold out of BioTelemetry, Inc. (BEAT) in Q2 2020, closing a stake of 2,155 shares — an estimated $96.6K sold.

Walleye Trading first reported a position in BEAT in Q2 2015 and held it in 9 quarters. The position peaked at $302K in Q1 2019. 215 funds tracked by Wall St. Rank hold BEAT as of Q2 2020.

  • Walleye Trading reported no remaining BioTelemetry, Inc. position as of Q2 2020 after selling out during the quarter.
  • Walleye Trading sold 2,155 BioTelemetry, Inc. shares in Q2 2020, an estimated $96.6K.
  • Walleye Trading first reported a position in BioTelemetry, Inc. in Q2 2015 and held it in 9 quarters.
  • Walleye Trading's BioTelemetry, Inc. position peaked at $302K in Q1 2019.
  • 215 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2020.

Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.